Webinar covering the background of anxious depression as a condition, current treatment options, BrainsWay's clinical efficacy and Deep TMS protocol, comparisons to Figure-8 and medication studies, how to think about patient identification, and more.
Dr. Aron Tendler, MD, CBSM
BrainsWay
Join us to discuss market access and OCD provider resources to drive demand. Other topics include best practices, evidence, coverage drivers, influencers, and more, as well as our resource center to assist with prior authorizations and appeals.
Scott Blackman
BrainsWay
Join Key Opinion Leader (KOL) Kimberly Cress, M.D. (Greenbrook TMS NeuroHealth Centers) and BrainsWay's Chief Medical Officer, Dr. Aron Tendler to discuss the current OCD treatment landscape, BrainsWay's Deep TMS™ therapy, and a robust body of clinical evidence.
Kimberly Cress, M.D. and Aron Tendler, M.D.
Greenbrook TMS and BrainsWay
